Market Overview:
The global neutrophil gelatinase-associated lipocalin (NGAL) test kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of acute kidney injury (AKI), rising geriatric population, and technological advancements in the field of NGAL testing. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment can be attributed to its advantages such as accuracy, speed, and low cost as compared with other methods such as ELISA and Western blotting. Based on application, hospitals are expected to account for the largest share ofthe global NGAL test kit market in 2018.
Product Definition:
A Neutrophil Gelatinase-associated Lipocalin Test Kit is a medical device used to measure the amount of neutrophil gelatinase-associated lipocalin (NGAL) in a blood or urine sample. NGAL is a protein that is released by damaged cells and can be detected in the blood or urine. The level of NGAL may be increased in people who have certain diseases, such as kidney damage, heart attack, and sepsis.
Immunochromatography:
It is one of the most important and commonly used techniques in proteomics research. The technique helps analyze different types of immune responses by measuring antibodies produced in response to foreign substances such as bacteria, viruses or even cancer cells.
Colloidal Gold Method:
Colloidal gold method is used for the detection of lipocalin, a protein localized to the cytoplasmic membrane in neutrophils. The test is based on an immunoassay technique and utilizes a specific monoclonal antibody that reacts with the extracellular domain of human lipocalin.
Application Insights:
Neutrophil gelatinase-associated lipocalin test is used to detect the presence of inflammatory Bowel Disease (IBD) including Crohn¢â‚¬â„¢s disease and ulcerative colitis. The increasing prevalence of IBD, especially in developed countries such as the U.S., Canada, Germany, and France is expected to drive demand over the forecast period. On basis of application, the global market has been segmented into hospital & clinical settings and hospital only settings. Clinic setting was estimated as largest revenue generating center owing to high usage rate in diagnosis of Inflammatory Bowel Disease (IBD).
The hospital & clinical settings segment dominated the global market with a share that stood at around 80% in 2017 owing to its wide usage for routine testing for Inflammatory Bowel Diseases (IBDs).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, increased research & development activities, and high healthcare expenditure in this region. Moreover, increasing incidence of chronic diseases such as cancer and diabetes is also expected to boost demand for NCglal test kits over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis among patients. In addition, government initiatives for improving healthcare infrastructure are expected to drive demand for NCglal tests over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The Neutrophil Gelatinase-associated Lipocalin Test Kit market is expected to benefit from this trend as more and more people seek diagnosis and treatment for various chronic diseases.
- Growing demand for personalized medicine: A major trend in the healthcare industry today is the growing demand for personalized medicine. This involves tailoring treatments to specific patients based on their individual genetic makeup or other factors such as lifestyle choices, age, etc. The Neutrophil Gelatinase-associated Lipocalin Test Kit market is expected to benefit from this trend as it enables more precise diagnosis and treatment of various medical conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neutrophil Gelatinase-associated Lipocalin Test Kit Market Research Report
By Type
Immunochromatography, Colloidal Gold Method
By Application
Hospital, Clinic
By Companies
Easydiagnosis, Biosino, V
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Neutrophil Gelatinase-associated Lipocalin Test Kit Market Report Segments:
The global Neutrophil Gelatinase-associated Lipocalin Test Kit market is segmented on the basis of:
Types
Immunochromatography, Colloidal Gold Method
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Easydiagnosis
- Biosino
- V
Highlights of The Neutrophil Gelatinase-associated Lipocalin Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunochromatography
- Colloidal Gold Method
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neutrophil Gelatinase-associated Lipocalin Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Neutrophil Gelatinase-associated Lipocalin Test Kit is a blood test that measures the level of neutrophil gelatinase-associated lipocalin (NGAL) in the blood. NGAL is a protein that is associated with inflammation and can be used to monitor the severity of an illness or injury. The test may be used to diagnose conditions such as sepsis, cancer, and autoimmune diseases.
Some of the major players in the neutrophil gelatinase-associated lipocalin test kit market are Easydiagnosis, Biosino, V.
The neutrophil gelatinase-associated lipocalin test kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neutrophil Gelatinase-associated Lipocalin Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neutrophil Gelatinase-associated Lipocalin Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neutrophil Gelatinase-associated Lipocalin Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neutrophil Gelatinase-associated Lipocalin Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size & Forecast, 2020-2028
4.5.1 Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size and Y-o-Y Growth
4.5.2 Neutrophil Gelatinase-associated Lipocalin Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunochromatography
5.2.2 Colloidal Gold Method
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunochromatography
9.6.2 Colloidal Gold Method
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunochromatography
10.6.2 Colloidal Gold Method
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunochromatography
11.6.2 Colloidal Gold Method
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunochromatography
12.6.2 Colloidal Gold Method
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunochromatography
13.6.2 Colloidal Gold Method
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neutrophil Gelatinase-associated Lipocalin Test Kit Market: Competitive Dashboard
14.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Easydiagnosis
14.3.2 Biosino
14.3.3 V
